Point72 Hong Kong LTD Corcept Therapeutics Inc Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $50,310 - $66,647	2,027 New	2,027 $65,000
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $156,351 - $228,256	-9,022 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $21,736 - $33,151	1,315 Added 17.06%	9,022 $203,000
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $97,384 - $132,921	5,695 Added 283.05%	7,707 $153,000
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $27,827 - $31,857	-1,414 Reduced 41.27%	2,012 $40,000
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $52,700 - $64,470	2,639 Added 335.32%	3,426 $75,000
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $23,325 - $30,346	-993 Reduced 55.79%	787 $19,000
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $29,868 - $48,594	1,780 New	1,780 $47,000
Q2 2020 Aug 14, 2020	SELL	$11.0 - $18.26 $2,739 - $4,546	-249 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $2,517 - $3,495	249 New	249 $3,000

368

86.8M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.29B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.